Lincocin
Active substance
ATC code
Species
Dogs, cats and pigs.
Indications
Dogs and cats
For the treatment of infections caused by lincomycin-susceptible Grampositive organisms, particularly Streptococci and Staphylococci, and certain Gram-negative anaerobic organisms e.g. Bacteroides spp. or Fusobacterium spp.
Tonsillitis, laryngitis and other upper respiratory tract infections: The product has proved effective against most causal organisms.
Abscesses, infected wounds and purulent dermatitis: The product has proved useful in clearing dermal infection since it readily penetrates tissues and maintains its action in the presence of purulent material.
Septicaemia: The product has been used successfully to combat septicaemic conditions caused by organisms sensitive to lincomycin.
Pigs
For the treatment of infections caused by lincomycin-susceptible Grampositive organisms, particularly Streptococci and Staphylococci, and certain Gram-negative anaerobic organisms e.g. Serpulina (treponema) hyodysenteriae, Bacteroides, Fusobacterium spp. and Mycoplasma spp. Swine dysentery: Lincocin Sterile Solution has been found effective in the treatment of swine dysentery. Lincocin Sterile Solution may be used in the inappetent pig when 1-2 injections with a 24 hour interval given intramuscularly at a dose of 10 mg/kg will normally be adequate to return the appetite. Follow-up treatment should be provided either in feed or via the drinking water.
Enzootic or mycoplasmal pneumonia: the product has antimycoplasmal activity, and will provide an effective aid in the treatment of primary infective organisms and the secondary Gram-positive pathogens.
Septic arthritis, foot abscesses: Where these conditions are caused by staphylococci, streptococci, erysipelothrix and mycoplasma sensitive to lincomycin, this antibiotic provides useful treatment by the virtue of its ability to penetrate relatively avascular tissue (e.g. joints) and remain active in the presence of purulent material.
Dose to be administered and administration route
For intramuscular or intravenous administration in dogs and cats. For intramuscular administration only in pigs.
Dogs and cats:
Intramuscular: 22 mg/kg bwt once daily or 11 mg/kg bwt.
Intravenous: 11-22 mg/kg bwt once or twice daily by slow injection.
Pigs:
Intramuscular: 4.5-11 mg/kg bwt once daily for a maximum of 3 days.
When injecting large volumes, a maximum of 10 mls per injection site should be administered. It is recommended that no more than two injections per day are given. At the lowest dose rate of 4.5 mg/kg, the maximum recommended weight of animal for treatment is therefore 445 kg and at the higher dose rate of 11 mg/kg, the maximum weight of animal for treatment will be 180 kg.
Adverse reactions
Not applicable.
References
Similar products
Showing 1 of 1 results
